Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component
Rate of mastectomy decreased significantly in HER2+ IBC treated with NST between 2010 and 2019. Presence of DCIS in the biopsy remained associated with higher mastectomy rate, yet 38.7 % of these patients do achieve ypT0.
Authors
- Adri C. Voogd (ORCID: https://orcid.org/0000-0002-8041-2720)
- Thiemo J. A. van Nijnatten (ORCID: https://orcid.org/0000-0002-6431-3538)
- Marjolein Louisa Smidt (ORCID: https://orcid.org/0000-0002-8328-1869)
- Roxanne A W Ploumen (ORCID: https://orcid.org/0000-0003-1024-3519)
- Loes F. S. Kooreman (ORCID: https://orcid.org/0000-0001-8226-8665)
- Sabine Siesling (ORCID: https://orcid.org/0000-0002-0273-824X)
- Kristien Keymeulen
Institutions
- Maastricht University Medical Centre (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
Publication Details
- Journal
- The Breast
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1016/j.breast.2024.103854
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00